Protein kinase CK2 (casein kinase 2) is a eukaryotic serine/threonine protein kinase with multiple substrates and roles in diverse cellular processes, including differentiation, proliferation, and translation. The mammalian holoenzyme consists of two catalytic alpha or alpha subunits and two regulatory beta subunits. We report the identification and characterization of a Plasmodium falciparum CK2␣ orthologue, PfCK2␣, and two PfCK2 orthologues, PfCK21 and PfCK22. Recombinant PfCK2␣ possesses protein kinase activity, exhibits similar substrate and cosubstrate preferences to those of CK2␣ subunits from other organisms, and interacts with both of the PfCK2 subunits in vitro. Gene disruption experiments show that the presence of PfCK2␣ is crucial to asexual blood stage parasites and thereby validate the enzyme as a possible drug target. PfCK2␣ is amenable to inhibitor screening, and we report differential susceptibility between the human and P. falciparum CK2␣ enzymes to a small molecule inhibitor. Taken together, our data identify PfCK2␣ as a potential target for antimalarial chemotherapeutic intervention.